Status:
COMPLETED
Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
UE LifeSciences Inc.
Earlier.org
Conditions:
Breast Screening
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study will test the iBreastExam device to find out whether it can detect a mass or lump in the breast as accurately as a routine breast cancer screening examination. The iBreastExam is a handhel...
Eligibility Criteria
Inclusion
- Female patient
- Over 18 years of age, able to consent
- RLC patients presenting to RLC or BAIC for mammogram and CBE
- Asymptomatic and symptomatic patients will be included
Exclusion
- Male patients
- Patients under 18 years of age, unable to consent
- Pregnant patients
- Lactating patients
- Non-intact skin
Key Trial Info
Start Date :
January 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 19 2025
Estimated Enrollment :
309 Patients enrolled
Trial Details
Trial ID
NCT04761055
Start Date
January 29 2021
End Date
August 19 2025
Last Update
August 27 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
MSK at Ralph Lauren (All Protocol Activities)
New York, New York, United States, 10035
2
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States, 10065